v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,718 $ 2,951
Accounts receivable, net of allowance of $114 in 2022 and $122 in 2021 2,659 2,629
Inventories 2,718 2,453
Prepaid expenses and other current assets 916 839
Total current assets 8,011 8,872
Property, plant and equipment, net 4,979 5,178
Goodwill 6,843 9,836
Other intangible assets 6,793 7,792
Operating lease right-of-use assets 550 630
Other non-current assets 1,111 1,213
Total assets 28,287 33,521
Current liabilities:    
Short-term debt 299 301
Current maturities of long-term debt and finance lease obligations 1,105 210
Accounts payable 1,139 1,246
Accrued expenses and other current liabilities 2,202 2,479
Total current liabilities 4,745 4,236
Long-term debt and finance lease obligations 15,232 17,149
Operating lease liabilities 456 522
Other non-current liabilities 1,959 2,493
Total liabilities 22,392 24,400
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021 683 683
Common stock in treasury, at cost, 179,062,594 shares in 2022 and 181,879,516 shares in 2021 (11,389) (11,488)
Additional contributed capital 6,322 6,197
Retained earnings 14,050 17,065
Accumulated other comprehensive (loss) income (3,833) (3,380)
Total Baxter stockholders’ equity 5,833 9,077
Noncontrolling interests 62 44
Total equity 5,895 9,121
Total liabilities and equity $ 28,287 $ 33,521